Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (4965)	5/22/1998 11:55:00 PM
From: Robert K.	Respond to of 9719

Thats "eludicating". I think the intensive worldwide research is just starting to explain the molecules approach to various infectious states. IMO a whole area of new ideas and approaches are cropping up. A quick visit to patents and medline tell the tale. Should you decide to take a look, let me know. I would be very interested in your viewpoint. BTW-we have quite a few astute medical types investing. Consensus is IMO positive. Oh yeah, bpi now in about 50+ hospitals.

To: scaram(o)uche who wrote (4965)	5/25/1998 3:30:00 AM
From: Peter Singleton	Read Replies (2) \| Respond to of 9719

Rick, provocative words on the NeuroInvestment website ... neuroinv.com "From 1999 on, the world of neuropharmaceutical treatments is going to be revolutionized by a series of new drugs. Neuropharmaceuticals will be to the beginning of the 21st Century what software, computer networking, and Internet stocks have been to the 1990's. The Time is Now, because by 1999, it will be far more costly to buy into companies that have moved ahead into the new pharmaceutical frontier." What's your opinion? Peter